Ananda Ghosh
Stock Analyst at HC Wainwright & Co.
(4.70)
# 155
Out of 5,138 analysts
19
Total ratings
66.67%
Success rate
45.06%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Maintains: Buy | $60 → $90 | $91.02 | -1.12% | 2 | Dec 19, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $32 → $37 | $26.29 | +40.74% | 1 | Dec 15, 2025 | |
| STOK Stoke Therapeutics | Maintains: Buy | $35 → $50 | $28.72 | +74.09% | 1 | Dec 15, 2025 | |
| DYN Dyne Therapeutics | Maintains: Buy | $46 → $60 | $16.58 | +261.88% | 2 | Dec 8, 2025 | |
| MAZE Maze Therapeutics | Maintains: Buy | $50 → $60 | $44.34 | +35.32% | 4 | Dec 3, 2025 | |
| PEPG PepGen | Maintains: Buy | $18 → $20 | $5.95 | +236.13% | 3 | Nov 13, 2025 | |
| RNA Avidity Biosciences | Downgrades: Neutral | $87 → $72 | $72.46 | -0.63% | 2 | Oct 27, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $24 | $6.43 | +273.25% | 2 | Oct 9, 2025 | |
| SKYE Skye Bioscience | Initiates: Buy | $20 | $0.97 | +1,955.71% | 1 | Sep 30, 2025 | |
| ANNX Annexon | Reiterates: Buy | $14 | $6.16 | +127.27% | 1 | Aug 15, 2025 |
Structure Therapeutics
Dec 19, 2025
Maintains: Buy
Price Target: $60 → $90
Current: $91.02
Upside: -1.12%
ACADIA Pharmaceuticals
Dec 15, 2025
Maintains: Buy
Price Target: $32 → $37
Current: $26.29
Upside: +40.74%
Stoke Therapeutics
Dec 15, 2025
Maintains: Buy
Price Target: $35 → $50
Current: $28.72
Upside: +74.09%
Dyne Therapeutics
Dec 8, 2025
Maintains: Buy
Price Target: $46 → $60
Current: $16.58
Upside: +261.88%
Maze Therapeutics
Dec 3, 2025
Maintains: Buy
Price Target: $50 → $60
Current: $44.34
Upside: +35.32%
PepGen
Nov 13, 2025
Maintains: Buy
Price Target: $18 → $20
Current: $5.95
Upside: +236.13%
Avidity Biosciences
Oct 27, 2025
Downgrades: Neutral
Price Target: $87 → $72
Current: $72.46
Upside: -0.63%
Inventiva
Oct 9, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $6.43
Upside: +273.25%
Skye Bioscience
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $0.97
Upside: +1,955.71%
Annexon
Aug 15, 2025
Reiterates: Buy
Price Target: $14
Current: $6.16
Upside: +127.27%